1. Home
  2. KPTI vs WRAP Comparison

KPTI vs WRAP Comparison

Compare KPTI & WRAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KPTI
  • WRAP
  • Stock Information
  • Founded
  • KPTI 2008
  • WRAP 2016
  • Country
  • KPTI United States
  • WRAP United States
  • Employees
  • KPTI N/A
  • WRAP N/A
  • Industry
  • KPTI Biotechnology: Pharmaceutical Preparations
  • WRAP Ordnance And Accessories
  • Sector
  • KPTI Health Care
  • WRAP Industrials
  • Exchange
  • KPTI Nasdaq
  • WRAP Nasdaq
  • Market Cap
  • KPTI 81.1M
  • WRAP 91.2M
  • IPO Year
  • KPTI 2013
  • WRAP N/A
  • Fundamental
  • Price
  • KPTI $0.62
  • WRAP $2.13
  • Analyst Decision
  • KPTI Strong Buy
  • WRAP
  • Analyst Count
  • KPTI 4
  • WRAP 0
  • Target Price
  • KPTI $5.00
  • WRAP N/A
  • AVG Volume (30 Days)
  • KPTI 751.1K
  • WRAP 148.0K
  • Earning Date
  • KPTI 02-19-2025
  • WRAP 11-14-2024
  • Dividend Yield
  • KPTI N/A
  • WRAP N/A
  • EPS Growth
  • KPTI N/A
  • WRAP N/A
  • EPS
  • KPTI N/A
  • WRAP N/A
  • Revenue
  • KPTI $148,442,000.00
  • WRAP $4,231,000.00
  • Revenue This Year
  • KPTI $4.47
  • WRAP N/A
  • Revenue Next Year
  • KPTI $7.35
  • WRAP N/A
  • P/E Ratio
  • KPTI N/A
  • WRAP N/A
  • Revenue Growth
  • KPTI 1.77
  • WRAP N/A
  • 52 Week Low
  • KPTI $0.58
  • WRAP $1.21
  • 52 Week High
  • KPTI $1.70
  • WRAP $4.29
  • Technical
  • Relative Strength Index (RSI)
  • KPTI 43.29
  • WRAP 57.39
  • Support Level
  • KPTI $0.58
  • WRAP $1.92
  • Resistance Level
  • KPTI $0.67
  • WRAP $2.07
  • Average True Range (ATR)
  • KPTI 0.05
  • WRAP 0.11
  • MACD
  • KPTI -0.00
  • WRAP -0.00
  • Stochastic Oscillator
  • KPTI 31.02
  • WRAP 87.50

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

About WRAP Wrap Technologies Inc.

Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.

Share on Social Networks: